Cargando…
The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma
Introduction: Intrahepatic cholangiocarcinoma (ICC) is one of the most highly heterogeneous malignant solid tumors; it is generally insensitive to clinical treatment and has a poor prognosis. Evidence suggests that abnormal neovascularization in the tumor microenvironment is an important cause of tr...
Autores principales: | Chen, Liwei, He, Yuchao, Han, Zhiqiang, Gong, Wenchen, Tian, Xiangdong, Guo, Lin, Guo, Hua, Song, Tianqiang, Chen, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870246/ https://www.ncbi.nlm.nih.gov/pubmed/36699464 http://dx.doi.org/10.3389/fgene.2022.1127753 |
Ejemplares similares
-
TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022) -
SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma
por: Ning, Shanglei, et al.
Publicado: (2018) -
SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma
por: Young, Terri L., et al.
Publicado: (2020) -
Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018) -
The novel miR-1269b-regulated protein SVEP1 induces hepatocellular carcinoma proliferation and metastasis likely through the PI3K/Akt pathway
por: Chen, Lu, et al.
Publicado: (2020)